Korea S.E.
03:30:00 05/07/2024 am IST
5-day change
1st Jan Change
5,460
KRW
+0.37%
-1.62%
-23.96%
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.
March 02, 2021 at 06:32 am IST
From January 1, 2021 to February 26, 2021, the company has repurchased 10,000 shares, representing 0.09% for KRW 102.71 million. With this, the company has completed the repurchase of 14,000 shares, representing 0.13% for KRW 143.66 million under the buyback announced on December 14, 2020.
Korean Drug Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/23/15
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.
02/21/02
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.
02/21/02
CI
Korean Drug Co., Ltd.'s Equity Buyback announced on December 14, 2020, has closed with 14,000 shares, representing 0.13% for KRW 143.66 million.
26/21/26
CI
Korean Drug Co., Ltd. announces an Equity Buyback for 14,000 shares.
14/20/14
CI
Korean Drug Co., Ltd. authorizes a Buyback Plan.
14/20/14
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.
11/19/11
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.
11/19/11
CI
Korean Drug Co., Ltd.’s Equity Buyback announced on December 11, 2018 has closed with 20,000 shares, for KRW 152.32 million.
06/19/06
CI
Korean Drug Co., Ltd. announces an Equity Buyback for 20,000 shares.
11/18/11
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
11/18/11
CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on March 8, 2016.
07/16/07
CI
Korean Drug Co. Ltd.'s Equity Buyback announced on March 8, 2016 has closed with 15,000 shares, representing 0.14% for KRW 104.64 million.
02/16/02
CI
Korean Drug Co. Ltd. announces an Equity Buyback for 15,000 shares.
08/16/08
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
08/16/08
CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on November 10, 2014.
09/15/09
CI
Korean Drug Co. Ltd.'s Equity Buyback announced on November 10, 2014 has closed with 20,000 shares, representing 0.18% for KRW 82.6 million.
02/15/02
CI
Korea Securities Finance Corporation acquired 3.64% stake in Korean Drug Co. Ltd..
09/15/09
CI
Korean Drug Co. Ltd. announces an Equity Buyback for 20,000 shares.
10/14/10
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
10/14/10
CI
Korea Securities Finance Corporation, Investment Arm acquired a 4.2% stake in Korean Drug Co. Ltd..
11/14/11
CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on September 3, 2013.
02/13/02
CI
Korean Drug Co. Ltd.’s Equity Buyback announced on September 3, 2013 has closed with 53,000 shares, representing 0.47% for KRW 170.43 million.
26/13/26
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
03/13/03
CI
Korean Drug Co. Ltd. announces an Equity Buyback for 53,000 shares.
03/13/03
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
KOREAN DRUG CO.,LTD is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.
More about the company
1st Jan change
Capi.
-23.96% 4.32Cr +24.53% 4.51TCr +30.99% 2.34TCr +24.13% 1.61TCr +21.15% 1.46TCr +68.67% 1.4TCr -0.05% 678.76Cr -13.29% 637.59Cr -8.87% 572.55Cr +13.53% 563.98Cr
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
KOREAN DRUG CO., LTD. 
